Table 2.
Effect | In Subjects Without Antihypertensive Treatment | In Subjects With Antihypertensive Treatment | ||||||
---|---|---|---|---|---|---|---|---|
N | OR | 95%CI | P Value | N | OR | 95%CI | P Value | |
Association with OAG | ||||||||
DPP(per 10 mm Hg) (unadjusted) | 1.039 | 0.72 | 0.57−9.92 | .008 | 1212 | 0.78 | 0.66−0.93 | .006 |
DPP (per 10 mm Hg) (adjusted) | 1.05 | 0.81–1.35 | .731 | 0.83 | 0.68–1.01 | .062 | ||
Association with POAG | ||||||||
DPP (per 10 mm Hg) (unadjusted) | 922 | 0.80 | 0.59–1.07 | .13 | 1060 | 0.69 | 0.56–0.85 | < 0.001 |
DPP (per 10 mm Hg) (adjusted) | 0.98 | 0.72–1.33 | .891 | 0.78 | 0.62–0.97 | .028 | ||
Association with PEXG | ||||||||
DPP (per 10 mm Hg) (unadjusted) | 117 | 0.76 | 0.51–1.13 | .18 | 152 | 1.10 | 0.79–1.52 | .58 |
DPP (per 10 mm Hg) (adjusted) | 1.39 | 0.81–2.37 | .235 | 0.90 | 0.58–1.41 | .653 |